It is not an MHRA-licensed medicine and is not intended to diagnose, treat, cure or prevent any disease
Vomiting Less common than nausea
Semaglutide Semaglutide activates the GLP-1 receptor and may help eligible patients manage appetite, food intake, blood-sugar response, and body weight as part of a physician-guided program
Health Connect integration automatically syncs your weight changes alongside your medication protocol
Adjusting Your Dose: When to Pause or Reduce Dose escalation should be paused or reduced for persistent nausea, severe diarrhoea, acute illness, pancreatitis symptoms, or before surgery
Scientific research indicates that these medications can lead to meaningful weight reduction and metabolic improvements when paired with lifestyle interventions